Actively Recruiting

Phase Not Applicable
Age: 18Years +
MALE
NCT06046131

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Led by Centre Hospitalier Universitaire de la Guadeloupe · Updated on 2025-11-17

3000

Participants Needed

2

Research Sites

834 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire de la Guadeloupe

Lead Sponsor

I

Institut National de la Santé Et de la Recherche Médicale, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographic origins of the individuals. The general objective of the project is to identify the clinical, genetic and environmental determinants (risk factors) of the evolution, progression and complications of the disease according to the treatment options. Identifying modifiable and non-modifiable prognostic determinants of disease progression is a major challenge. This knowledge will help guide treatment choices but also, especially in high-risk populations (high incidence of disease) to better tailor prevention policies and possibly screening .

CONDITIONS

Official Title

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult male patients with a new diagnosis of prostate cancer
  • Patients consulting at the University Hospital of Guadeloupe or the University Hospital of Rennes
  • Patients residing in Guadeloupe, Martinique, Saint-Martin, or Brittany
  • Patients affiliated with or beneficiaries of social security
  • Signed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Physical or mental health conditions that prevent participation, as judged by the investigator
  • Adults under legal protection such as guardianship, curatorship, or safeguard of justice

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHU of Rennes

Rennes, Ille-et-Vilaine, France, 35000

Not Yet Recruiting

2

CHU of Guadeloupe

Pointe-à-Pitre, Guadeloupe, Guadeloupe, 97159

Actively Recruiting

Loading map...

Research Team

V

Valérie HAMONY-SOTER

CONTACT

E

Eunice NUBRET

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here